Patents by Inventor Susan R. Atlas

Susan R. Atlas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification of novel subgroups of high-risk pediatric precursor B acute lymphoblastic leukemia, outcome correlations and diagnostic and therapeutic methods related to same
    Patent number: 8568974
    Abstract: The present invention relates to the identification of genetic markers patients with high risk B-precursor acute lymphoblastic leukemia (B-ALL) and associated methods and their relationship to therapeutic outcome. The present invention also relates to diagnostic, prognostic and related methods using these genetic markers, as well as kits which provide microchips and/or immunoreagents for performing analysis on leukemia patients.
    Type: Grant
    Filed: November 14, 2008
    Date of Patent: October 29, 2013
    Assignees: STC.UNM, Sandia Corporation
    Inventors: Cheryl L. Willman, Richard Harvey, George S. Davidson, Xuefei Wang, Susan R Atlas, Edward J. Bedrick, Iming L. Chen
  • GENE EXPRESSION CLASSIFIERS FOR RELAPSE FREE SURVIVAL AND MINIMAL RESIDUAL DISEASE IMPROVE RISK CLASSIFICATION AND OUTCOME PREDICTION IN PEDIATRIC B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Publication number: 20110230372
    Abstract: The present invention relates to the identification of genetic markers patients with leukemia, especially including acute lymphoblastic leukemia (ALL) at high risk for relapse, especially high risk B-precursor acute lymphoblastic leukemia (B-ALL) and associated methods and their relationship to therapeutic outcome. The present invention also relates to diagnostic, prognostic and related methods using these genetic markers, as well as kits which provide microchips and/or immunoreagents for performing analysis on leukemia patients.
    Type: Application
    Filed: November 16, 2009
    Publication date: September 22, 2011
    Inventors: Cheryl L. Willman, Richard Harvey, Huining Kang, Edward Bedrick, Xuefei Wang, Susan R. Atlas, I-Ming Chen
  • IDENTIFICATION OF NOVEL SUBGROUPS OF HIGH-RISK PEDIATRIC PRECURSOR B ACUTE LYMPHOBLASTIC LEUKEMIA, OUTCOME CORRELATIONS AND DIAGNOSTIC AND THERAPEUTIC METHODS RELATED TO SAME
    Publication number: 20110045999
    Abstract: The present invention relates to the identification of genetic markers patients with high risk B-precursor acute lymphoblastic leukemia (B-ALL) and associated methods and their relationship to therapeutic outcome. The present invention also relates to diagnostic, prognostic and related methods using these genetic markers, as well as kits which provide microchips and/or immunoreagents for performing analysis on leukemia patients.
    Type: Application
    Filed: November 14, 2008
    Publication date: February 24, 2011
    Applicants: STC.UNM, Sandia Corporation
    Inventors: Cheryl L. Willman, Richard Harvey, George S. Davidson, Xuefei Wang, Susan R Atlas, Edward J. Bedrick, Iming L. Chen
  • Outcome prediction and risk classification in childhood leukemia
    Publication number: 20090203588
    Abstract: Genes and gene expression profiles useful for predicting outcome, risk classification, cytogenetics and/or etiology in pediatric acute lymphoblastic leukemia (ALL). OPAL1 is a novel gene associated with outcome and, along with other newly identified genes, represent a novel therapeutic targets.
    Type: Application
    Filed: June 8, 2007
    Publication date: August 13, 2009
    Inventors: Cheryl L. Willman, Paul Helman, Robert Veroff, Monica Mosquera-Caro, George S. Davidson, Shawn B. Martin, Susan R. Atlas, Erik Andries, Huining Kang, Jonathan J. Shuster, Xuefei Wang, Richard C. Harvey, David M. Haaland, Jeffrey W. Potter